Moleculin Biotech Inc. (MBRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Moleculin Biotech Inc.

    NASDAQ: MBRX · Real-Time Price · USD
    0.50
    -0.03 (-5.66%)
    At close: Oct 02, 2025, 3:59 PM

    Moleculin Biotech Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 4.28M 23.55M 43.15M 70.9M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 159K n/a n/a n/a
    Receivables
    		 20K 99K 22K 45K
    Inventory
    		 n/a n/a -22K -45K
    Other Current Assets
    		 331K 545K 823K 531K
    Total Current Assets
    		 5.19M 26.27M 45.6M 72.5M
    Property-Plant & Equipment
    		 424K 796K 678K 445K
    Goodwill & Intangibles
    		 11.15M 11.15M 11.15M 11.15M
    Total Long-Term Assets
    		 11.73M 11.94M 11.83M 11.59M
    Total Assets
    		 16.93M 38.22M 57.42M 84.09M
    Account Payables
    		 2.03M 2.5M 2.1M 1.36M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 120K 100K 116K 96K
    Other Current Liabilities
    		 1.27M -100K -116K 1.46M
    Total Current Liabilities
    		 5.36M 6.82M 4.82M 3.62M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 5.23M 4.86M 77K 1.41M
    Total Long-Term Liabilities
    		 5.59M 5.33M 412K 1.48M
    Total Liabilities
    		 10.95M 12.14M 5.23M 5.1M
    Total Debt
    		 478K 574K 451K 159K
    Book Value
    		 5.98M 26.07M 52.19M 78.99M
    Book Value Per Share
    		 1.74 13.20 27.37 44.09
    Common Stock
    		 3K 33K 29K 29K
    Retained Earnings
    		 -153.37M -131.6M -101.83M -72.81M
    Comprehensive Income
    		 -41K -9K 12K 41K
    Shareholders Equity
    		 5.98M 26.07M 52.19M 78.99M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist